Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) reached a new 52-week low during trading on Thursday . The stock traded as low as GBX 4.32 ($0.05) and last traded at GBX 2,134 ($26.65), with a volume of 784546 shares. The stock had previously closed at GBX 2,130 ($26.60).
Hikma Pharmaceuticals Stock Performance
The stock has a fifty day simple moving average of GBX 1,972.07 and a two-hundred day simple moving average of GBX 1,937.30. The firm has a market capitalization of £4.73 billion, a P/E ratio of 3,276.92, a P/E/G ratio of 2.38 and a beta of 0.41. The company has a debt-to-equity ratio of 55.48, a current ratio of 1.66 and a quick ratio of 1.27.
Hikma Pharmaceuticals Company Profile
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.
Featured Articles
- Five stocks we like better than Hikma Pharmaceuticals
- 5 Top Rated Dividend Stocks to Consider
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Airline Stocks – Top Airline Stocks to Buy Now
- 3 Buy-and-Hold Stocks for Long-Term Growth
- What is a Secondary Public Offering? What Investors Need to Know
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
